1. Home
  2. IKT vs INTT Comparison

IKT vs INTT Comparison

Compare IKT & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.50

Market Cap

111.8M

Sector

Health Care

ML Signal

HOLD

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$7.87

Market Cap

94.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IKT
INTT
Founded
2008
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
111.8M
94.9M
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
IKT
INTT
Price
$1.50
$7.87
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$12.00
AVG Volume (30 Days)
354.4K
36.7K
Earning Date
11-14-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$117,606,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$5.24
52 Week High
$4.20
$9.77

Technical Indicators

Market Signals
Indicator
IKT
INTT
Relative Strength Index (RSI) 46.90 49.67
Support Level $1.40 $7.33
Resistance Level $1.61 $8.29
Average True Range (ATR) 0.11 0.49
MACD -0.01 0.03
Stochastic Oscillator 38.46 63.16

Price Performance

Historical Comparison
IKT
INTT

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: